Systematic account of animal poisonings in Germany, 2012-2015.

A systematic retrospective study on animal poisonings in Germany (wildlife excluded) between January 2012 and December 2015 was conducted. Data were collected on animal exposure calls to German poison centres, poisoning cases presenting to the University of Veterinary Medicine, Hannover Small Animal and Equine Clinics, cases involving off-label use of veterinary medicinal products reported to the Federal Office of Consumer Protection and Food Safety and toxicological submissions to the Institute of Pharmacology, Toxicology, and Pharmacy, Faculty of Veterinary Medicine, Ludwig-Maximilians-University, Munich. Descriptive statistics were used to characterise animal type, exposure reason, type and substance, year/month of exposure, case severity and outcome. An evaluation of the data and data sources was also carried out. Variation in poisoning patterns was seen. However, dogs and cats were the most frequently reported species and medicinal products, pesticides and plants were consistently implicated as top causes of poisoning. Advantages and disadvantages were associated with each data source; bias was found to be an important consideration when evaluating poisoning data. This study provided useful information on animal poisonings in Germany and highlights the need for standardised approaches for the collection, evaluation and integration of poisoning data from multiple sources.

Determination of ceftiofur derivatives in serum, endometrial tissue, and lochia in puerperal dairy cows with fever or acute puerperal metritis after subcutaneous administration of ceftiofur crystalline free acid.

Acute puerperal metritis (APM) is one of the most common diseases during the puerperal period. Systemic administration of ceftiofur for 5 consecutive days has been shown to be effective for treatment of APM. The objective of this study was to determine concentrations of ceftiofur derivatives in serum, endometrial tissue, and lochia of cows with fever postpartum or APM 4 to 6d after treatment with a single subcutaneous dose of 6.6 mg of ceftiofur crystalline free acid (CCFA)/kg of estimated BW at the base of the ear. In the first experiment, samples from CCFA-treated cows with fever postpartum or APM (n=42) were taken on d 4, 5, or 6 after treatment. Concentrations of ceftiofur derivatives were quantified using an HPLC assay. Concentrations of active ceftiofur metabolite desfuroylceftiofuracetamide (DCA) were greatest at d 4 after treatment with CCFA in all samples, but they were considerably lower than the concentrations of DCA in healthy postpartum cows treated with the same dose of CCFA. The concentrations of DCA in serum, endometrial tissue, and lochia were affected by odor of vaginal discharge before treatment with CCFA. Mean concentrations of DCA could be detected above the reported minimal drug concentrations (minimum inhibitory concentrations, MIC) required to inhibit relevant pathogens such as Escherichia coli and Arcanobacterium pyogenes in serum on all days and in endometrial tissue and lochia only on d 4 in CCFA-treated cows with fetid vaginal discharge before treatment. In the second experiment, samples from CCFA-treated cows with APM (n=8) were taken on d 0 (before treatment) and d 4, 5, and 6 after treatment. Mean concentrations of DCA in serum and lochia were similar on d 4 to 6 in both laboratories. Furthermore, determined concentrations of DCA from both laboratories were correlated for serum and lochia. Mean concentrations of DCA could be detected above the reported MIC in serum and lochia only on d 4. Our 2 experiments demonstrated that in postpartum cows with fever postpartum or APM concentrations above the MIC for relevant bacteria (>0.5 µg/mL or >0.5 µg/g) of DCA could be sustained only for 4 (serum: 15/17; endometrial tissue: 2/17; lochia: 1/16) to 5d (serum: 10/13; endometrial tissue: 1/13; lochia: 2/12) after a single treatment with CCFA only in a certain proportion of cows. Overall, our data provide first pharmacological evidence that a single subcutaneous administration of 6.6g of CCFA/kg of BW might not be sufficient to efficaciously treat APM in postpartum dairy cows.

Short communication: Evaluation of vaginal discharge following treatment with a progesterone insert.

Yellowish discharge after application of intravaginal progesterone releasing inserts is frequently observed in cows. The objective of this study was to compare the bacteriological contamination of the vagina and uterus before and after a treatment with a progesterone insert in heifers. Forty-two Holstein heifers received a progesterone releasing insert [Eazi-Breed controlled internal drug release (CIDR) insert; Pfizer Animal Health, Berlin, Germany] for 7d. The protruding tail had been removed from half of the inserts (no tail group: n=21; tail group: n=21). Nine heifers from the tail group lost the insert within the 7-d treatment interval and were excluded. Heifers identified in estrus were artificially inseminated on d 9 or 10. Vaginal discharge was scored on a 4-point scale [vaginal discharge score (VDS) 0 to 3] and vaginal swabs were taken for bacteriological examination on d 0 and 7 and the day of artificial insemination (AI). Furthermore, cytological and bacteriological samples were obtained from the uterus on d 7 and the day of AI. On d 0, coliforms and Streptococcus spp. were found in vaginal swabs of 21 heifers (64%). On d 7, all heifers showed purulent vaginal discharge (VDS 2 to 3). The VDS was higher in the tail group compared with the no tail group. Arcanobacterium pyogenes, coliforms, and Streptococcus spp. were isolated from the vaginal swabs in 32 of 33 (96%) heifers on d 7. On the day of AI, VDS had improved to 0 or 1 in 96% of the heifers. However, A. pyogenes, coliforms, and Streptococcus spp. were still isolated in 17 of 33 (53%) heifers from the vagina and in 32 of 33 (96%) heifers from the endometrium. Endometrial cytology revealed polymorphonuclear neutrophils (PMN) in 11 heifers (6 to 32% PMN). Five samples exceeded the threshold of 5% PMN, and 2 samples exceeded the 10% PMN threshold, indicative of subclinical endometritis. In conclusion, pyogenic bacteria were found in the vagina and uterus on d 7 and the day of AI after intravaginal progesterone treatment. The severity of the discharge was affected by the protruding tail of the insert.

[Efficacy of vaginal progesterone inserts (CIDR) to reduce early embryonic losses in dairy cows]. / Wirksamkeit einer vaginalen Progesteronspange zur Verringerung embryonaler Verluste in der Frühträchtigkeit bei Milchkühen.

UNLABELLED: The OBJECTIVE of this study was to test the efficacy of a progesterone releasing device (CIDR®, Pfizer, Germany) inserted on day (d) 20 post insemination (p.i.) to reduce embryonic losses between d 27 and 39 p.i. Furthermore, we hypothesized that CIDR® increases blood progesterone levels during the application period, but does not affect the maintenance of pregnancy after removal. MATERIAL AND METHODS: The study was conducted on a commercial dairy farm, randomly allocating 74 Holstein Friesian cows to one of two groups. These cows were non-pregnant after previous artificial insemination and treated with an Ovsynch protocol. Group 1 (n=36) received a CIDR® on d 20 p.i. (CIDR® group) while group 2 (n=38) remained untreated (control group). CIDR® was removed on d 39 p.i. Blood samples were drawn from all cows on d 20, 27, 39 and 55 p.i. for analysis of progesterone (P4) concentrations by immunoassay (ADVIA Centaur®, Siemens, Germany). Pregnancy diagnosis was conducted on d 27 p.i. with ultrasonography, and on d 39 and 55 p.i. by transrectal palpation. RESULTS: The overall prevalence rate of early embryonic losses between d 27 and 39 p.i. was 37.1% (CIDR® group 35.3%, control group 38.9%; p=0.83). On d 39 p.i. 30.5% of all cows were pregnant and the percentage of pregnant cows did not differ between the study groups (p=0.83). Progesterone levels on d 20 p.i. did not differ among cows which were pregnant on d 39 p.i. (p=0.57). On d 27 p.i. progesterone levels in pregnant cows were higher in the CIDR® group (16.2 ± 9.9 ng/ml) compared to the control group (11.2 ± 3.4 ng/ml; p=0.04). Progesterone concentrations were lower on d 39 p.i., but still differed between study groups (p=0.05). After removal of CIDR®, blood progesterone levels did not differ between pregnant cows of both study groups on d 55 p.i. (p=0.36). CONCLUSION: The application of a progesterone releasing device led to increased blood progesterone levels during the application period, but did not affect maintenance of pregnancy after its removal. CLINICAL RELEVANCE: Supplementation with progesterone at d 20 p.i. does not decrease early embryonic losses between d 27 and 39 p.i. or increase the number of cows pregnant on d 39 p.i.

Evaluation of vaginoscopy for the diagnosis of clinical endometritis in dairy cows.

The objective of the study was to evaluate the visual assessment of vaginal discharge by vaginoscopy for the diagnosis of clinical endometritis (CE) in dairy cows. In an in vivo trial, inter- and intraobserver repeatability of vaginoscopic examination (VE) was determined and the effect of transrectal palpation and experience of the investigator evaluated. Holstein-Friesian cows (n=380) were examined by vaginoscopy between 21 and 27 d in milk by 3 investigators twice. Vaginal discharge was categorized on a 4-point classification system (0=clear mucus, 1=mucus containing flecks of pus, 2=discharge containing less than 50% pus, 3=discharge containing more than 50% pus). Cows with a vaginal discharge score (VDS) of 0 were classified as healthy, whereas cows with a VDS of 1 to 3 were classified as having CE. Vaginal discharge score on a scale from 0 to 3 has moderate intra- (Cohen's kappa coefficient, κ=0.55-0.60) and interobserver (κ=0.44) repeatability. The prevalence of CE was comparable between the 3 investigators (first VE: 42.6, 34.8, and 38.7; second VE 46.8, 36.9, and 43.7%). Transrectal palpation (relative risk=0.96-1.03) or experience of the investigator (relative risk=0.9-1.1) did not affect results of VE. In an in vitro trial, sensitivity and specificity of visual assessment were determined utilizing 33 images showing yellow and pink areas in certain percentages as a reference standard. Pus was represented by yellow areas and the mucosa, including clear mucus, by pink areas. These images were visually assessed by 30 investigators via PowerPoint presentation (experiment 1) and by 23 investigators via a simulated vaginal examination (experiment 2) utilizing the same 4-point classification system. Sensitivity was 99.6 and 96.3% and specificity was 96.7 and 90.1% in experiments 1 and 2, respectively. The results provide evidence that a visual assessment conducted by vaginoscopic examination is not perfect but can be considered a reasonable measurement of vaginal discharge and is a practical tool to distinguish healthy from diseased cows.

Effect of CIDR® on 4-day-service-rate, pregnancy rate and vaginal irritation in dairy heifers.

OBJECTIVE: The objective of this study was to compare reproductive performance parameters for two protocols for estrus synchronization in dairy heifers in Germany. MATERIAL AND METHODS: In the CIDR group (n=93) all heifers received a controlled intravaginal progesterone releasing insert (Eazi-Breed™ CIDR®; Pfizer Pharma GmbH; containing 1,38g of progesterone) on day 0. On day 7 these cows were given prostaglandin F2α (PGF2α) analogue cloprostenol (Estrumate®, Intervet Deutschland GmbH, 0.5mg per animal i.m.), and the CIDR® insert was removed. Any mucus attached to the insert was scored on a 4-point scale: 0=no mucus; 1=clear; 2=bloody; 3=yellow/cloudy mucus. In the PG group (n=98) all heifers were given PGF2α analogue cloprostenol on day 7. Between day 8 and 11 heat detection was conducted twice daily for 30 minutes. All heifers in estrus were bred by artificial insemination (AI) and pregnancy was diagnosed 40 days after AI by transrectal palpation. RESULTS: In the CIDR group the 4-day-service rate was 91.4%, in the PG group 70.4% (p<0.05). More heifers in the CIDR group were pregnant than in the PGF2α protocol (76.3 vs. 56.1%,p<0.05). Mucus scores of 2 and 3 indicative of vaginal irritation were observed in 91.9% of the CIDR group but did not affect the pregnancy outcome (OR = 0.652, CI95 =0.235-1.810; p=0.411). CONCLUSION: In conclusion, the CIDR protocol improved reproductive parameters of dairy heifers compared with a PGF2α protocol. Mucus after removal of the CIDR® insert did not affect pregnancy rates.

Effect of flunixin meglumine and carprofen on pregnancy rates in dairy cattle.

Embryonic losses contribute considerably to low pregnancy rates. Between d 8 and 17 after breeding, the conceptus secretes interferon-τ as a mechanism for maternal recognition of pregnancy and maintenance of the corpus luteum. Nonsteroidal antiinflammatory drugs inhibit the synthesis of prostaglandin F(2α) by suppressing the enzyme cyclooxygenase. Flunixin meglumine (FM) has been demonstrated to delay luteolysis and to support embryonic survival. The objective of this study was to evaluate the effect of FM and carprofen on conception rates in dairy heifers and cows, respectively. In experiment 1, the effect of FM on pregnancy rates and progesterone concentrations in dairy heifers was tested. A total of 391 heifers were randomly assigned to 1 of 2 groups. Heifers in the treatment group (n=197) received 2.2 mg of FM i.m./kg of body weight twice on d 14/15 and 15/16 after insemination, whereas heifers in the control group (n=194) remained untreated. Blood samples from 388 heifers were taken on d 14/15 and 21/22 after artificial insemination and analyzed for progesterone. Pregnancy rates were 58.2 and 54.8% for the control and treatment groups, respectively. Mean progesterone concentrations were not affected by treatment and number of artificial insemination service (first or second artificial insemination service), but were affected by time and time × pregnancy status. In experiment 2, the objective was to verify the effects of carprofen, a longer acting nonsteroidal antiinflammatory drug and to evaluate its effect on conception rate to first service in dairy cows. A total of 380 cows were randomly assigned to 1 of 2 treatment groups. Cows in the treatment group (n=194) received 1.4 mg of carprofen s.c./kg of body weight on d 15 after insemination, whereas cows in the control group (n=186) remained untreated. Pregnancy was diagnosed between d 40 and 47 after insemination. Conception rates to first service were 35.5 and 33.0% in the control and treatment groups, respectively. Neither flunixin meglumine nor carprofen improved conception rates to first service in dairy cattle in the dosage and administration schedule tested.